The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has ...

AM(IST)on Wednesday in a weak market. Sun Pharmaceutical Industries Ltd.(up 0.21 per cent) were among the top gainers. J B Chemicals & Pharmaceuticals Ltd.(down 5.05 per cent), Natco Pharma Ltd.(down ...

Defence Minister Rajnath Singh projected Bengaluru as the epicentre of India’s technological future, asserting that the city ...

Bangalore: Syngene International Limited has announced that Jonathan Hunt has stepped down from his role as MD & CEO as well as from the Board of Directors to pursue other opportunities in ...

In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...

Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global ...

Equillium (EQ) and Biocon announced topline results from the Phase 2 study evaluating itolizumab in the treatment of moderate to severe ...

Health, the leading global mental health solution for employers and health plans, today unveiled data from a peer-reviewed study that validates the return on investment (ROI) of employer-sponsored ...

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

Biocon Ltd is quoting at Rs 397.1, up 1.76% on the day as on 12:49 IST on the NSE. The stock is up 36.81% in last one year as compared to a 7.61% gain in NIFTY and a 18.78% gain in the Nifty Pharma ...

Veteran Indian origin global banker Victor Menezes passes away at 77. Biocon Ltd founder and executive chairperson Kiran Mazumdar-Shaw tweeted the death of Menezes on her X accoun ...